Intravitreal pegcetacoplan for GA: Phase 3 results of OAKS and DERBY studies
October 11, 2021
David Boyer, MD, reports on the use of pegcetacoplan to treat geographic atrophy when administered monthly or every-other-month regimens in the phase 3 DERBY and OAKS studies.